| 000 | 01725 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513144925.0 | ||
| 264 | 0 | _c19980901 | |
| 008 | 199809s 0 0 eng d | ||
| 022 | _a0903-1936 | ||
| 024 | 7 |
_a10.1183/09031936.98.11051091 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBoulet, L P | |
| 245 | 0 | 0 |
_aTolerance to the protective effects of salmeterol on methacholine-induced bronchoconstriction: influence of inhaled corticosteroids. _h[electronic resource] |
| 260 |
_bThe European respiratory journal _cMay 1998 |
||
| 300 |
_a1091-7 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadministration & dosage |
| 650 | 0 | 4 |
_aAdrenergic beta-Agonists _xtherapeutic use |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAlbuterol _xanalogs & derivatives |
| 650 | 0 | 4 |
_aAsthma _xdiagnosis |
| 650 | 0 | 4 | _aBronchoconstrictor Agents |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Tolerance |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aForced Expiratory Volume _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMethacholine Chloride |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPeak Expiratory Flow Rate _xdrug effects |
| 650 | 0 | 4 | _aSalmeterol Xinafoate |
| 700 | 1 | _aCartier, A | |
| 700 | 1 | _aMilot, J | |
| 700 | 1 | _aCôté, J | |
| 700 | 1 | _aMalo, J L | |
| 700 | 1 | _aLaviolette, M | |
| 773 | 0 |
_tThe European respiratory journal _gvol. 11 _gno. 5 _gp. 1091-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1183/09031936.98.11051091 _zAvailable from publisher's website |
| 999 |
_c9615095 _d9615095 |
||